.Nature Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for introduction of patients with MASLD and measurement of liver results in cardio-- kidney-- metabolic tests, when data propose mechanistically probable advantages and professional protection-- as well as lays out factors to consider for trial style and also regulatory commendation.